Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cheney

Showing results (371-380 of 389) with videos related to

Pageof 39
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 3, 2017
Neutral macrocyclic factor VIIa inhibitorsNicholas R Wurtz, Brandon L Parkhurst, Indawati DeLucca, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2013
Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitorsPeter W Glunz, Xiaojun Zhang, Yan Zou, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, James A Johnson, Andrew Viet, et al.
The Journal of Experimental Biology|July 22, 2025
Emerging frontiers in visual ecologyEleanor M Caves, Karen L Cheney, Marie Dacke, et al.
Journal of Medicinal Chemistry|July 26, 2016
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor ComplexXiaojun Zhang, Peter W Glunz, James A Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffoldDominique Potin, Michele Launay, Eric Nicolai, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa InhibitorsXiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2013
Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffoldScott A Bolton, James C Sutton, Rushith Anumula, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activityKevin R Guertin, Charles J Gardner, Scott I Klein, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, Pravin S Shirude, Daniel L Cheney, et al.
Pageof 39

Showing results (371-380 of 389) with videos related to

Sort By:
Pageof 39
Bioorganic & Medicinal Chemistry Letters|May 3, 2017
Neutral macrocyclic factor VIIa inhibitorsNicholas R Wurtz, Brandon L Parkhurst, Indawati DeLucca, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2013
Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitorsPeter W Glunz, Xiaojun Zhang, Yan Zou, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, James A Johnson, Andrew Viet, et al.
The Journal of Experimental Biology|July 22, 2025
Emerging frontiers in visual ecologyEleanor M Caves, Karen L Cheney, Marie Dacke, et al.
Journal of Medicinal Chemistry|July 26, 2016
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor ComplexXiaojun Zhang, Peter W Glunz, James A Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffoldDominique Potin, Michele Launay, Eric Nicolai, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa InhibitorsXiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2013
Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffoldScott A Bolton, James C Sutton, Rushith Anumula, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activityKevin R Guertin, Charles J Gardner, Scott I Klein, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, Pravin S Shirude, Daniel L Cheney, et al.
Pageof 39